Clinical Trial Update: BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial to determine the ED95 dose of remimazolam for sedation during arteriovenous fistula creation surgery in patients with uremia; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremia

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Gang Chen | Conditions: Uremia | Phase 4 | Status: NOT_YET_RECRUITING